How to Screen Anxiety Before ECT for Depression Response Risk
How can clinicians use baseline anxiety assessment to identify patients with depression who may be less likely to respond to ECT?
Many patients referred for ECT have depression with prominent anxiety symptoms, and anxiety burden may affect the likelihood of antidepressant response. This guide focuses on the baseline anxiety-screening approach supported by the study's findings in a community ECT clinic.
-
Administer a baseline GAD-7 before the first ECT treatment
Assess anxiety symptoms with the GAD-7 at the first ECT treatment. In the study, patients completed the GAD-7 prior to each ECT session, and the authors specifically examined anxiety level at the first treatment as a potential predictor of depression response.
-
Identify severe baseline anxiety using the study cutoff
Use a GAD-7 score of 15 or higher to identify severe anxiety. Patients with initial severe anxiety scores were less likely than other patients to show depression response on the PHQ-9.
-
Use the severe-anxiety group to frame response expectations
In this sample, patients with initial severe anxiety had a 41.7% depression response rate on the PHQ-9, compared with 81.8% among patients without severe anxiety. This makes baseline severe anxiety a practical marker for counseling that depression response to ECT may be less likely.
-
Do not treat the raw baseline GAD-7 score as a stand-alone predictor
Initial GAD-7 score itself did not predict PHQ-9 response rates in logistic regression, with an odds ratio of 0.950 and P=.523. The article therefore supports using the severe-anxiety category as an informative risk marker rather than assuming a linear relationship between higher baseline GAD-7 scores and lower ECT response.
-
Monitor anxiety change during the ECT course
Continue to repeat the GAD-7 prior to each treatment and assess for anxiety response, defined as a 50% or greater reduction in score. Improvement in GAD-7 was significantly associated with both PHQ-9 response and HAMD-17 response during the course of ECT.
Clinical Considerations
- The study found an association between severe baseline anxiety and lower depression response, but it did not establish causation.
- Baseline anxiety was measured at the first ECT treatment, so the study could not distinguish preexisting anxiety from anxiety related to starting ECT.
- Initial GAD-7 score as a continuous measure did not predict PHQ-9 response, so anxiety screening should not be overinterpreted as a precise individual prognostic tool.
- The findings come from a small community sample of highly treatment-resistant patients and may not generalize to all ECT populations.
Bottom Line
Before starting ECT for severe depression, screen anxiety with the GAD-7 and recognize that a baseline score of 15 or higher identifies patients in this community sample who were less likely to achieve depression response.
